4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Frontal Lobe Oxyhemoglobin Levels in Patients With Lower Extremity Burns Assessed Using a fNIRS (fNIRS)

Frontal Lobe Oxyhemoglobin Levels in Patients With Lower Extremity Burns Assessed Using a fNIRS (fNIRS)

Study Description
Brief Summary:
Investigators investigate the patterns of cortical activation using the NIRST in patients with peripheral neurological injury caused by lower extremity burns.

Condition or disease Intervention/treatment Phase
Walking Diagnostic Test: Functional near-infrared spectroscopy (fNIRS) Not Applicable

Detailed Description:

Understanding the mechanisms associated with locomotor networks may be of benefit for rehabilitation of burn victims with neurological locomotor deficits. However, the effects of peripheral neurological injury on locomotor network remains unknown. A wearable functional near-infrared spectroscopy (fNIRS) device has been developed for studying cortical hemodynamics. Changes in cortical activity has not previously been documented in patients with burn injury.

Investigators assessed 15 patients with lower extremity burns and 11 healthy controls.

Investigators measured walking-related cortical activity using an fNIRS device at baseline and during usual walking.

Cortical activity was measured by evaluating relative changes in oxyhemoglobin level. The NIRST Analysis Tool v2.1 was utilized to analyze fNIRS data in a MATLAB environment.

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: patients with lower extremity burn : 15 patients patients with upper extremity burn : 10 patients healthy controls : 11
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Frontal Lobe Oxyhemoglobin Levels in Patients With Lower Extremity Burns Assessed Using a Functional Near-Infrared Spectroscopy Device During Usual Walking: A Pilot Study
Actual Study Start Date : July 9, 2019
Actual Primary Completion Date : July 9, 2019
Actual Study Completion Date : July 9, 2019
Arms and Interventions
Arm Intervention/treatment
burn injury and normal patient
HbO2 PFC perfusion using fNIRS
Diagnostic Test: Functional near-infrared spectroscopy (fNIRS)
Functional near-infrared spectroscopy (fNIRS) measurement

Outcome Measures
Primary Outcome Measures :
  1. oxygenated hemoglobin (HbO2) of the prefrontal regions, [ Time Frame: 5 minutes ]
    identify the location of the normal cortical activation during usual walking


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • burn patients with lower extremity or upper extremity thermal injury
  • patients who could walk unassisted for at least 5min.

Exclusion Criteria:

  • patients with critical systemic conditions
  • severe cognitive impairment
  • had severe pain
  • unable to walk.
Contacts and Locations

Locations
Layout table for location information
Korea, Republic of
Hangang Sacred Heart Hospital
Seoul, Yeongdeungpo-Ku, Korea, Republic of, 150-719,
Sponsors and Collaborators
Hangang Sacred Heart Hospital
National Research Foundation of Korea
Investigators
Layout table for investigator information
Principal Investigator: Cheong Hoon Seo, M.D. Hangang Sacred Heart Hospital
Tracking Information
First Submitted Date  ICMJE February 21, 2019
First Posted Date  ICMJE June 19, 2019
Last Update Posted Date July 10, 2019
Actual Study Start Date  ICMJE July 9, 2019
Actual Primary Completion Date July 9, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: June 18, 2019)
oxygenated hemoglobin (HbO2) of the prefrontal regions, [ Time Frame: 5 minutes ]
identify the location of the normal cortical activation during usual walking
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Frontal Lobe Oxyhemoglobin Levels in Patients With Lower Extremity Burns Assessed Using a fNIRS
Official Title  ICMJE Frontal Lobe Oxyhemoglobin Levels in Patients With Lower Extremity Burns Assessed Using a Functional Near-Infrared Spectroscopy Device During Usual Walking: A Pilot Study
Brief Summary Investigators investigate the patterns of cortical activation using the NIRST in patients with peripheral neurological injury caused by lower extremity burns.
Detailed Description

Understanding the mechanisms associated with locomotor networks may be of benefit for rehabilitation of burn victims with neurological locomotor deficits. However, the effects of peripheral neurological injury on locomotor network remains unknown. A wearable functional near-infrared spectroscopy (fNIRS) device has been developed for studying cortical hemodynamics. Changes in cortical activity has not previously been documented in patients with burn injury.

Investigators assessed 15 patients with lower extremity burns and 11 healthy controls.

Investigators measured walking-related cortical activity using an fNIRS device at baseline and during usual walking.

Cortical activity was measured by evaluating relative changes in oxyhemoglobin level. The NIRST Analysis Tool v2.1 was utilized to analyze fNIRS data in a MATLAB environment.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description:
patients with lower extremity burn : 15 patients patients with upper extremity burn : 10 patients healthy controls : 11
Masking: None (Open Label)
Primary Purpose: Diagnostic
Condition  ICMJE Walking
Intervention  ICMJE Diagnostic Test: Functional near-infrared spectroscopy (fNIRS)
Functional near-infrared spectroscopy (fNIRS) measurement
Study Arms  ICMJE burn injury and normal patient
HbO2 PFC perfusion using fNIRS
Intervention: Diagnostic Test: Functional near-infrared spectroscopy (fNIRS)
Publications *
  • Al-Yahya E, Johansen-Berg H, Kischka U, Zarei M, Cockburn J, Dawes H. Prefrontal Cortex Activation While Walking Under Dual-Task Conditions in Stroke: A Multimodal Imaging Study. Neurorehabil Neural Repair. 2016 Jul;30(6):591-9. doi: 10.1177/1545968315613864. Epub 2015 Oct 21.
  • Kim HY, Kim EJ, You JSH. Adaptive locomotor network activation during randomized walking speeds using functional near-infrared spectroscopy. Technol Health Care. 2017 Jul 20;25(S1):93-98. doi: 10.3233/THC-171310.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: July 8, 2019)
36
Original Estimated Enrollment  ICMJE
 (submitted: June 18, 2019)
35
Actual Study Completion Date  ICMJE July 9, 2019
Actual Primary Completion Date July 9, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • burn patients with lower extremity or upper extremity thermal injury
  • patients who could walk unassisted for at least 5min.

Exclusion Criteria:

  • patients with critical systemic conditions
  • severe cognitive impairment
  • had severe pain
  • unable to walk.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 20 Years to 60 Years   (Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Korea, Republic of
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03990831
Other Study ID Numbers  ICMJE HangangSHH-1
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party So Young Joo, Hangang Sacred Heart Hospital
Study Sponsor  ICMJE Hangang Sacred Heart Hospital
Collaborators  ICMJE National Research Foundation of Korea
Investigators  ICMJE
Principal Investigator: Cheong Hoon Seo, M.D. Hangang Sacred Heart Hospital
PRS Account Hangang Sacred Heart Hospital
Verification Date July 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP